These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35192472)

  • 1. Managing obesity in people with type 2 diabetes.
    Grant B; Sandelson M; Agyemang-Prempeh B; Zalin A
    Clin Med (Lond); 2021 Jul; 21(4):e327-e231. PubMed ID: 35192472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of weight in the management of patients with type 2 diabetes mellitus: towards an adipocentric approach to diabetes.
    Gorgojo Martínez JJ
    Med Clin (Barc); 2016 Nov; 147 Suppl 1():8-16. PubMed ID: 28760227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM).
    Gourdy P; Darmon P; Dievart F; Halimi JM; Guerci B
    Cardiovasc Diabetol; 2023 Apr; 22(1):79. PubMed ID: 37005640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical and surgical management of obesity and diabetes: what's new?
    Ammori BJ; Skarulis MC; Soran H; Syed AA; Eledrisi M; Malik RA
    Diabet Med; 2020 Feb; 37(2):203-210. PubMed ID: 31850536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging treatment options for type 2 diabetes.
    Piya MK; Tahrani AA; Barnett AH
    Br J Clin Pharmacol; 2010 Nov; 70(5):631-44. PubMed ID: 20831513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bariatric surgery versus medications in the treatment of type 2 diabetes.
    Fanin A; Benetti A; Ceriani V; Pontiroli AE
    Minerva Endocrinol; 2015 Dec; 40(4):297-306. PubMed ID: 26365477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
    Palmer SC; Tendal B; Mustafa RA; Vandvik PO; Li S; Hao Q; Tunnicliffe D; Ruospo M; Natale P; Saglimbene V; Nicolucci A; Johnson DW; Tonelli M; Rossi MC; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque LI; Lloyd A; Ahmad N; Liu Y; Tiv S; Millard T; Gagliardi L; Kolanu N; Barmanray RD; McMorrow R; Raygoza Cortez AK; White H; Chen X; Zhou X; Liu J; Rodríguez AF; González-Colmenero AD; Wang Y; Li L; Sutanto S; Solis RC; Díaz González-Colmenero F; Rodriguez-Gutierrez R; Walsh M; Guyatt G; Strippoli GFM
    BMJ; 2021 Jan; 372():m4573. PubMed ID: 33441402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
    Lau DC; Teoh H
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing patients with type 2 diabetes and obesity.
    Wilding J
    Practitioner; 2015 Jan; 259(1778):25-8, 3. PubMed ID: 25726618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).
    Al-Ozairi E; Narula K; Miras AD; Taghadom E; Samad AE; Al Kandari J; Alyosef A; Mashankar A; Al-Najim W; le Roux CW
    Trials; 2024 Feb; 25(1):129. PubMed ID: 38365744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study.
    Wu T; Wong CKH; Tang EHM; Man KKC; Wong SKH; Au ICH; Tse ETY; Chan EWY; Grieve E; Wu O; Ng EKW; Wong ICK
    Surg Obes Relat Dis; 2022 Jun; 18(6):762-771. PubMed ID: 35300912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperglycaemia in people with obesity.
    Mourougavelou V; Chowdhury TA
    Clin Med (Lond); 2023 Jul; 23(4):364-371. PubMed ID: 37524409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons from bariatric surgery: Can increased GLP-1 enhance vascular repair during cardiometabolic-based chronic disease?
    Bakbak E; Terenzi DC; Trac JZ; Teoh H; Quan A; Glazer SA; Rotstein OD; Al-Omran M; Verma S; Hess DA
    Rev Endocr Metab Disord; 2021 Dec; 22(4):1171-1188. PubMed ID: 34228302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses.
    McGlone ER; Carey I; Veličković V; Chana P; Mahawar K; Batterham RL; Hopkins J; Walton P; Kinsman R; Byrne J; Somers S; Kerrigan D; Menon V; Borg C; Ahmed A; Sgromo B; Cheruvu C; Bano G; Leonard C; Thom H; le Roux CW; Reddy M; Welbourn R; Small P; Khan OA
    PLoS Med; 2020 Dec; 17(12):e1003228. PubMed ID: 33285553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Diabetes in Patients Undergoing Bariatric Surgery.
    Mulla CM; Baloch HM; Hafida S
    Curr Diab Rep; 2019 Nov; 19(11):112. PubMed ID: 31686263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.
    Yska JP; van Roon EN; de Boer A; Leufkens HG; Wilffert B; de Heide LJ; de Vries F; Lalmohamed A
    JAMA Surg; 2015 Dec; 150(12):1126-33. PubMed ID: 26422580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(8):1-151. PubMed ID: 38130940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and adverse events of bariatric surgery in adults with severe obesity in Scotland: the SCOTS observational cohort study.
    Mackenzie RM; Ali A; Bruce D; Bruce J; Ford I; Greenlaw N; Grieve E; Lean M; Lindsay RS; O'Donnell J; Sattar N; Stewart S; Logue J;
    Health Technol Assess; 2024 Jan; 28(7):1-115. PubMed ID: 38343107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.